BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 12369210)

  • 1. [New aspects of ICD therapy: from rhythm therapy to complex cardiac monitoring. Development of an implantable, ICD-assisted, intrathoracic 6-channel ECG for continuous monitoring of high infarct risk patients].
    Grom A; Zehender M
    Biomed Tech (Berl); 2002 Oct; 47(9-10):234-8. PubMed ID: 12369210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological detection algorithms for the automatic implantable cardioverter/defibrillator (AICD).
    Kaup HJ; Hexamer M; Werner J
    Biomed Tech (Berl); 2004 Nov; 49(11):306-10. PubMed ID: 15624867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification for arrhythmic death after myocardial infarction: current perspective and future direction.
    Arya A; Haghjoo M; Sadr-Ameli MA
    Int J Cardiol; 2006 Apr; 108(2):155-64. PubMed ID: 15964087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computerized vectorcardiography for improved perioperative cardiac monitoring in vascular surgery.
    Gannedahl PE; Edner M; Ljungqvist OH
    J Am Coll Surg; 1996 Jun; 182(6):530-6. PubMed ID: 8646354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: rationale and design of the Defibrillator After Primary Angioplasty (DAPA) trial.
    Ottervanger JP; Ramdat Misier AR; Zijlstra F; Schalij MJ; Wever E; Jordaens LJ; Henriques JP; de Boer MJ; Robbe HW; Wellens HJ;
    Am Heart J; 2006 Oct; 152(4):636-40. PubMed ID: 16996827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
    Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
    Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
    Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
    J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of intracardial electrograms in pacemakers and ICD systems by Biotronik].
    Wetzel U; Piorkowski C; Richter S; Müssigbrodt A; Kucher A; Hindricks G
    Herzschrittmacherther Elektrophysiol; 2010 Mar; 21(1):6-17. PubMed ID: 20309671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators.
    Sredniawa B; Mazurek M; Lenarczyk R; Kowalski O; Kowalczyk J; Kalarus Z
    Future Cardiol; 2010 May; 6(3):315-23. PubMed ID: 20462338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AICD treatment in 2004--state of the art.
    Budde T
    Eur J Med Res; 2006 Oct; 11(10):432-8. PubMed ID: 17107877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate Risk-Stratification Improves Survival (IRIS): study protocol.
    Steinbeck G; Andresen D; Senges J; Hoffmann E; Seidl K; Brachmann J;
    Europace; 2004 Sep; 6(5):392-9. PubMed ID: 15294263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML; Wilber DJ; Klein HU;
    J Am Coll Cardiol; 2006 May; 47(9):1811-7. PubMed ID: 16682305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The implantable cardioverter-defibrillator: sometimes necessary].
    Smeets JL
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2113-5. PubMed ID: 15553353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
    Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
    Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable defibrillator therapy.
    Alings AM
    Neth J Med; 2003 May; 61(5 Suppl):4-7. PubMed ID: 12918543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
    Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
    Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.